Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07323017Active Not Recruiting

Electrochemotherapy in Musculoskeletal Tumors

Role: lead

NCT06524843Recruiting

Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Role: lead

NCT06522165Active Not Recruiting

Pediatric Oncological Orthopaedic Reconstruction

Role: lead

NCT06918860Recruiting

Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur

Role: lead

NCT06486506Recruiting

Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic Results

Role: lead

All 5 trials loaded